Effect of heavy smoking on prognosis of patients received concurrent chemoradiotherapy followed by total mesorectal excision

Jin-liang ZHANG,Hui-yun WANG,Guo-liang XU,Qing YANG,Shi-yong LIN,Hong-bo SHAN

2015-01-01

Abstract:OBJECTIVE To investigate the inftuances of cigarette smoking on survival of rectal cancer patients received neoadjuvant concurrent chemoradiotherapy followed radical surgery.METHODS Medical data of 125 consecutive rectal cancer patients who received the same regimen of neoadjuvant concurrent chemoradiotherapy followed by radical surgery in our hospital were collected between July 1,2008 and June 30,2011.Three dimensional conformal radiotherapy (3D-CRT) was delivered in a total dose of 46 Gy (23 fractions in 5 weeks),and the concurrent chemotherapy regimen was XELOX (Oxaliplatin+Capecitabine).Patients were separated into heavy smokers (≥20 pack-years,83 cases) and nonheavy smokers (＜20 pack-years,42 cases) according to the smoking index,which was defined as the product of the number of packs consumed per day and years of smoking.Influences of cigarette smoking on neoadjuvant chemoradiotherapy efficacy,tumor recurrence and prognosis were analyzed.RESULTS The efficacy of chemoradiotherapy between heavy smokers and non-heavy smoker was not significantly different (x2=0.11,P=0.739),while recurrence between the two groups was significantly different (x2 =4.35,P=0.037).Binary Logistic analysis showed that heavy smokers were independent factors of recurrence (Wald=5.00,P=0.026).The disease-free survival and overall survival of patientswith non-heavy smoking were significantly better than those with heavy smoking (x2 value was 4.719 and 5.729,respectively;P value was 0.030 and 0.017,respectively).Multivariate Cox regression model analysis showed that heavy smoking was an independent risk factor for disease-free survival (Wald=6.20; RR=3.52,95％CI:1.31-9.47; P=0.013) and overall survival (Wald=5.21; RR=3.18,95％CI:1.17-8.58; P=0.023).CONCLUSIONS Cigarette smoking has no effect on efficacy of concurrent chemoradiotherapy for rectal cancer,while smoking is significantly correlated with tumor recurrence and survival of patients with rectal cancer.